- Home
- REE vs IVVD Comparison
REE vs IVVD Comparison
Compare REE & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- IVVD
- Stock Information
- Founded
- REE 2011
- IVVD 2020
- Country
- REE Israel
- IVVD United States
- Employees
- REE N/A
- IVVD N/A
- Industry
- REE Auto Manufacturing
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- IVVD Health Care
- Exchange
- REE Nasdaq
- IVVD Nasdaq
- Market Cap
- REE 77.3M
- IVVD 69.0M
- IPO Year
- REE N/A
- IVVD 2021
- Fundamental
- Price
- REE $0.61
- IVVD $0.75
- Analyst Decision
- REE Strong Buy
- IVVD Strong Buy
- Analyst Count
- REE 2
- IVVD 3
- Target Price
- REE $11.75
- IVVD $5.85
- AVG Volume (30 Days)
- REE 238.9K
- IVVD 1.8M
- Earning Date
- REE 07-01-2025
- IVVD 08-13-2025
- Dividend Yield
- REE N/A
- IVVD N/A
- EPS Growth
- REE N/A
- IVVD N/A
- EPS
- REE N/A
- IVVD N/A
- Revenue
- REE $183,000.00
- IVVD $36,688,000.00
- Revenue This Year
- REE $7,039.34
- IVVD $446.60
- Revenue Next Year
- REE $2,159.93
- IVVD $112.63
- P/E Ratio
- REE N/A
- IVVD N/A
- Revenue Growth
- REE N/A
- IVVD N/A
- 52 Week Low
- REE $0.61
- IVVD $0.35
- 52 Week High
- REE $11.72
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- REE 24.83
- IVVD 43.27
- Support Level
- REE $0.62
- IVVD $0.70
- Resistance Level
- REE $0.67
- IVVD $1.03
- Average True Range (ATR)
- REE 0.05
- IVVD 0.07
- MACD
- REE 0.07
- IVVD -0.03
- Stochastic Oscillator
- REE 3.10
- IVVD 12.75
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.